← All trials
NCT02959359
Phase 4Interventional
Studies of FDA-approved drugs to delineate additional information including the drug's risks, benefits, and optimal use.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 1, 2016
- Primary completion
- Jun 1, 2022
- Completion date
- Dec 1, 2022
- First posted
- —
- Last posted
- —
- Enrollment
- 130
- Arms / groups
- 1 / —
- Source
- AACT · pre-existing
Sponsors
- Taipei Veteran General hospitalLead sponsor
- Chiayi Christian HospitalCollaborator
- Government of TaiwanCollaborator
- National Taiwan UniversityCollaborator
- Kaohsiung Medical UniversityCollaborator
- Chang Gung UniversityCollaborator
- National Cheng Kung UniversityCollaborator
- Chimei Medical CenterCollaborator
- China Medical UniversityCollaborator
- Taipei Veteran General hospitalOverall official - principal investigator
- Taipei Veteran General hospitalReponsible party - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.